Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia
- PMID: 8468314
Relationship of past depressive episodes to symptom severity and treatment response in panic disorder with agoraphobia
Abstract
Background: Many investigators have reported that panic disorder (PD) patients with comorbid major depression (MD) have more severe symptoms and a poorer response to treatment than patients with PD alone. It is not known if this is due to a distinct and more serious underlying disorder in these patients or simply a result of the simultaneous presence of the two disorders.
Method: Nondepressed patients presenting for treatment of panic disorder with agoraphobia (PDA) were studied before treatment (N = 180) and after 4 weeks of treatment with adinazolam sustained release (N = 89) or placebo (N = 91). Twenty-nine percent (N = 53) of the patients had a past history of MD. Symptom severity and treatment outcome were compared in patients with primary, secondary, single, recurrent, or no past MD.
Results: There were no consistent differences in symptom severity or treatment outcome in patients with a past history of primary, secondary, or single episode MD compared with patients with no history of MD. However, a small number of patients with history of recurrent MD exhibited consistently greater symptom severity and poorer response to treatment than patients with no history of MD.
Conclusion: The greater severity and worse outcome of comorbid PD and MD observed in earlier studies are more likely due to the simultaneous presence of the two disorders than to a more serious and enduring underlying disorder. However, our results suggest that recurrent MD may indicate a more serious condition in patients with PDA. This possibility warrants further study.
Similar articles
-
Adinazolam-SR in panic disorder with agoraphobia: relationship of daily dose to efficacy.J Clin Psychiatry. 1995 May;56(5):202-10. J Clin Psychiatry. 1995. PMID: 7737960 Clinical Trial.
-
The impact of comorbidity on the treatment of panic disorder.J Clin Psychiatry. 1998;59 Suppl 8:11-4; discussion 15-6. J Clin Psychiatry. 1998. PMID: 9707157 Review.
-
Moderators and mediators among panic, agoraphobia symptoms, and suicidal ideation in patients with panic disorder.Compr Psychiatry. 2010 May-Jun;51(3):243-9. doi: 10.1016/j.comppsych.2009.07.005. Epub 2009 Aug 28. Compr Psychiatry. 2010. PMID: 20399333
-
Personality disorder comorbidity in panic disorder patients with or without current major depression.Depress Anxiety. 2002;15(4):176-82. doi: 10.1002/da.10050. Depress Anxiety. 2002. PMID: 12112723
-
Comorbidity of depression and panic disorder.J Clin Psychiatry. 1996;57 Suppl 10:34-41; discussion 42-3. J Clin Psychiatry. 1996. PMID: 8917130 Review.
Cited by
-
Benzodiazepines versus placebo for panic disorder in adults.Cochrane Database Syst Rev. 2019 Mar 28;3(3):CD010677. doi: 10.1002/14651858.CD010677.pub2. Cochrane Database Syst Rev. 2019. PMID: 30921478 Free PMC article.
-
History of depressive and anxiety disorders and paroxetine response in patients with irritable bowel syndrome: post hoc analysis from a placebo-controlled study.Prim Care Companion J Clin Psychiatry. 2008;10(5):368-75. doi: 10.4088/pcc.v10n0504. Prim Care Companion J Clin Psychiatry. 2008. PMID: 19158975 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical
Miscellaneous